Mary E. Grimley

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

Cystic fibrosis

Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance

Palliative and end-of-life care in cystic fibrosis: what we know and what we need to know

Predicting behavior problems in deaf and hearing children: The influences of language, attention, and parent–child communication

Cystic fibrosis genetics: from molecular understanding to clinical application

Spoken Language Development in Children Following Cochlear Implantation

Update on Key Emerging Challenges in Cystic Fibrosis

Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry

Prevalence and impact of depression in cystic fibrosis

Improvements in visual attention in deaf infants and toddlers after cochlear implantation